Julien Carvelli Selected Research

Julien Carvelli Research Topics

9	COVID-19 01/2023 - 11/2020
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 12/2017
4	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 11/2020
3	Pneumonia (Pneumonitis) 01/2023 - 11/2020
3	Cytokine Release Syndrome 01/2021 - 01/2019
2	Infections 01/2023 - 01/2019
2	Acute Kidney Injury (Acute Renal Failure) 10/2022 - 11/2016
2	Hypertension (High Blood Pressure) 10/2022 - 01/2019
2	Neoplasms (Cancer) 09/2022 - 01/2022
2	Thrombosis (Thrombus) 11/2021 - 01/2021
2	Inflammation (Inflammations) 01/2021 - 11/2020
2	Fever (Fevers) 11/2020 - 07/2017
2	Lymphopenia (Lymphocytopenia) 01/2020 - 01/2019
2	Sepsis (Septicemia) 01/2020 - 01/2019
1	Unconsciousness (Loss of Consciousness) 12/2023
1	Critical Illness (Critically Ill) 10/2022
1	Myasthenia Gravis 09/2022
1	Myocarditis (Carditis) 09/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 09/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Contusions 01/2022
1	Hemorrhagic Shock 01/2022
1	Aspiration Pneumonia 01/2022
1	Out-of-Hospital Cardiac Arrest 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Acute Lung Injury 12/2020
1	Bacterial Infections (Bacterial Infection) 11/2020
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2019
1	Vasculitis (Vasculitides) 11/2016
1	Aneurysm (Aneurysms) 11/2016
1	Hemorrhage 11/2016

3	Biomarkers (Surrogate Marker)IBA 12/2022 - 11/2020
2	Immune Checkpoint InhibitorsIBA 09/2022 - 01/2022
2	Complement System Proteins (Complement)IBA 04/2021 - 01/2021
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2021 - 11/2020
1	N- (2- hydroxybenzyl)- 2- (4- iodo- 2,5- dimethoxyphenyl)ethan- 1- aminiumIBA 12/2023
1	PowdersIBA 12/2023
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2023
1	avdoralimabIBA 12/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2022
1	Salivary alpha-AmylasesIBA 01/2022
1	Amylases FDA Link 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2021
1	ruxolitinibIBA 02/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Monoclonal AntibodiesIBA 12/2020
1	Oxygen (Dioxygen)IBA 11/2020
1	Interleukin-1 (Interleukin 1)IBA 11/2020
1	C-Reactive ProteinIBA 11/2020
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	CytokinesIBA 11/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2020
1	lopinavir-ritonavir drug combination (Kaletra)FDA Link 05/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 05/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 05/2020
1	PerforinIBA 01/2020
1	InterferonsIBA 01/2020
1	HLA-DR Antigens (HLA-DR)IBA 01/2019
1	CreatinineIBA 01/2019
1	Neuromuscular Blocking AgentsIBA 12/2017
1	ProcalcitoninIBA 07/2017
1	Ferritins (Ferritin)IBA 07/2017
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2016

5	Artificial Respiration (Mechanical Ventilation) 01/2023 - 01/2019
2	Therapeutics 04/2021 - 01/2021
1	Mechanical Ventilators (Ventilator) 01/2023
1	Induced Hypothermia 01/2022
1	Extracorporeal Membrane Oxygenation 01/2022
1	Critical Care (Surgical Intensive Care) 01/2019
1	Contraindications 11/2016